Brain scans prove Freud right: Guilt plays key role in depression
2012-06-05
(Press-News.org) Scientists have shown that the brains of people with depression respond differently to feelings of guilt – even after their symptoms have subsided.
University of Manchester researchers found that the brain scans of people with a history of depression differed in the regions associated with guilt and knowledge of socially acceptable behaviour from individuals who never get depressed.
The study – published in the journal Archives of General Psychiatry – provides the first evidence of brain mechanisms to explain Freud's classical observation that exaggerated guilt and self-blame are key to understanding depression.
Lead researcher Dr Roland Zahn, from the University's School of Psychological Sciences, said: "Our research provides the first brain mechanism that could explain the classical observation by Freud that depression is distinguished from normal sadness by proneness to exaggerated feelings of guilt or self-blame.
"For the first time, we chart the regions of the brain that interact to link detailed knowledge about socially appropriate behaviour – the anterior temporal lobe – with feelings of guilt – the subgenual region of the brain – in people who are prone to depression."
The study used functional magnetic resonance imaging (fMRI) to scan the brains of a group of people after remission from major depression for more than a year, and a control group who have never had depression. Both groups were asked to imagine acting badly, for example being 'stingy' or 'bossy' towards their best friends. They then reported their feelings to the research team.
"The scans revealed that the people with a history of depression did not 'couple' the brain regions associated with guilt and knowledge of appropriate behaviour together as strongly as the never depressed control group do," said Dr Zahn, a MRC Clinician Scientist Fellow.
"Interestingly, this 'decoupling' only occurs when people prone to depression feel guilty or blame themselves, but not when they feel angry or blame others. This could reflect a lack of access to details about what exactly was inappropriate about their behaviour when feeling guilty, thereby extending guilt to things they are not responsible for and feeling guilty for everything."
The research, part-funded by the Medical Research Council (MRC), is important because it reveals brain mechanisms underlying specific symptoms of depression that may explain why some people react to stress with depression rather than aggression.
The team is now investigating whether the results from the study can be used to predict depression risk after remission of a previous episode. If successful, this could provide the first fMRI marker of risk of future depression.
###
Notes for editors:
A copy of the paper, 'Guilt-Selective Functional Disconnection of Anterior Temporal and Subgenual Cortices in Major Depressive Disorder,' by Sophie Green, Matthew Lambon Ralph, Bill Deakin and Roland Zahn (University of Manchester) and Jorge Moll (D'Or Institute for Research and Education, Rio de Janeiro), is available on request.
More on the study can be found at: http://www.psych-sci.manchester.ac.uk/staff/RolandZahn
Details of the ongoing study, funded by the MRC, can be found here: http://www.medicine.manchester.ac.uk/blamebiases
About the MRC:
For almost 100 years the Medical Research Council has improved the health of people in the UK and around the world by supporting the highest quality science. The MRC invests in world-class scientists. It has produced 29 Nobel Prize winners and sustains a flourishing environment for internationally recognised research. The MRC focuses on making an impact and provides the financial muscle and scientific expertise behind medical breakthroughs, including one of the first antibiotics penicillin, the structure of DNA and the lethal link between smoking and cancer. Today MRC funded scientists tackle research into the major health challenges of the 21st century.
www.mrc.ac.uk
END
ELSE PRESS RELEASES FROM THIS DATE:
2012-06-05
DURHAM, N.C.— An ambitious effort to coordinate heart attack care among every hospital and emergency service in North Carolina improved patient survival rates and reduced the time from diagnosis to treatment, according to Duke University Medical Center researchers who spearheaded the program.
"When treating heart attacks, the most important care decisions need to take place before the patient is brought to the hospital," says James Jollis, M.D., a Duke cardiologist and first author of the findings published today in the journal Circulation. "These procedures should be ...
2012-06-05
CHICAGO – An observational study that examined the comparative effectiveness of rhythm control vs. rate control drug treatment on mortality in patients with atrial fibrillation (a rapid, irregular heart beat) suggests there was little difference in mortality within four years of treatment, but rhythm control may be associated with more effective long-term outcomes, according to a report published Online First by Archives of Internal Medicine, a JAMA Network publication.
AF affects approximately 2.3 million Americans and 250,000 Canadians, and the condition has a complex ...
2012-06-05
Family members of children with a staph infection often harbor a drug-resistant form of the germ, although they don't show symptoms, a team of researchers from Washington University School of Medicine in St. Louis has found.
The results are published in the June issue of Archives of Pediatrics & Adolescent Medicine.
The investigators focused on family members of nearly 200 children who had Staphylococcus aureus infections in the skin and soft tissue, in areas such as the nose, armpits and/or groin. They found that of the more than 600 household members who lived with ...
2012-06-05
BOSTON -- June 4, 2012 -- Researchers at Joslin Diabetes Center have shown that while a type of "good" fat found in the body can be activated by cold temperatures, it is not able to be activated by the drug ephedrine.
The finding, published in today's issue of PNAS USA Early Edition, may lead to drugs or other methods aimed at activating the good fat, known as brown fat. When activated, brown fat burns calories and can help in the battle against obesity.
"We propose that agents that work similarly to cold in activating brown fat specifically can provide promising approaches ...
2012-06-05
Analyzing medical records from thousands of patients, statisticians have devised a statistical model for predicting what other medical problems a patient might encounter.
Like how Netflix recommends movies and TV shows or how Amazon.com suggests products to buy, the algorithm makes predictions based on what a patient has already experienced as well as the experiences of other patients showing a similar medical history.
"This provides physicians with insights on what might be coming next for a patient, based on experiences of other patients. It also gives a predication ...
2012-06-05
PASADENA, Calif.—A nuzzle of the neck, a stroke of the wrist, a brush of the knee—these caresses often signal a loving touch, but can also feel highly aversive, depending on who is delivering the touch, and to whom. Interested in how the brain makes connections between touch and emotion, neuroscientists at the California Institute of Technology (Caltech) have discovered that the association begins in the brain's primary somatosensory cortex, a region that, until now, was thought only to respond to basic touch, not to its emotional quality.
The new finding is described ...
2012-06-05
A three-drug treatment for the blood cancer multiple myeloma provided rapid, deep and potentially durable responses, researchers report today online in Blood, the Journal of the American Society of Hematology, and yesterday, Sunday, June 3, 2012, at the American Society of Clinical Oncology's Annual Meeting in Chicago, IL, USA.
The researchers, led by Andrzej J. Jakubowiak, M.D., Ph.D., professor of medicine and director of the multiple myeloma program at the University of Chicago Medical Center, found that combining carfilzomib, a next generation proteasome inhibitor, ...
2012-06-05
VIDEO:
As a retrovirus matures, the two parts of its shell protein (red and blue or yellow and blue) dramatically rearrange themselves, twisting and moving away from each other.
Click here for more information.
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany, have for the first time uncovered the detailed structure of the shell that surrounds the genetic material of retroviruses, such as HIV, at a crucial and potentially vulnerable stage ...
2012-06-05
VIDEO:
A fruit fly embryo from when it was about two-and-a-half hours old until it walked away from the microscope as a larva, filmed by a new microscope developed at EMBL....
Click here for more information.
"This video shows a fruit fly embryo from when it was about two-and-a-half hours old until it walked away from the microscope as a larva, 20 hours later," says Lars Hufnagel, from the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany. "It shows all ...
2012-06-05
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany, have conducted the first comprehensive census of human cells' export workers. In a study published online today in Nature Cell Biology, they found an unexpected variety of genes involved in transporting molecules to the cell membrane and beyond.
Using a combination of genetics and sophisticated microscopy, Rainer Pepperkok and colleagues systematically silenced each of our 22 000 genes, and observed to what extent this affected the cell's ability to transport a protein. They found that ...
LAST 30 PRESS RELEASES:
[Press-News.org] Brain scans prove Freud right: Guilt plays key role in depression
